Annual epidemiological and health insurance disease burden of hip osteoarthritis in Hungary based on nationwide data
- PMID: 38783258
- PMCID: PMC11112791
- DOI: 10.1186/s12891-024-07513-y
Annual epidemiological and health insurance disease burden of hip osteoarthritis in Hungary based on nationwide data
Abstract
Background: Health services utilization related to hip osteoarthritis imposes a significant burden on society and health care systems. Our aim was to analyse the epidemiological and health insurance disease burden of hip osteoarthritis in Hungary based on nationwide data.
Methods: Data were extracted from the nationwide financial database of the National Health Insurance Fund Administration (NHIFA) of Hungary for the year 2018. The analysed data included annual patient numbers, prevalence, and age-standardized prevalence per 100,000 population in outpatient care, health insurance costs calculated for age groups and sexes for all types of care. Patients with hip osteoarthritis were identified using code M16 of the International Classification of Diseases (ICD), 10th revision. Age-standardised prevalence rates were calculated using the European Standard Population 2013 (ESP2013).
Results: Based on patient numbers of outpatient care, the prevalence per 100,000 among males was 1,483.7 patients (1.5%), among females 2,905.5 (2.9%), in total 2,226.2 patients (2.2%). The age-standardised prevalence was 1,734.8 (1.7%) for males and 2,594.8 (2.6%) for females per 100,000 population, for a total of 2,237.6 (2.2%). The prevalence per 100,000 population was higher for women in all age groups. In age group 30-39, 40-49, 50-59, 60-69 and 70 + the overall prevalence was 0.2%, 0.8%, 2.7%, 5.0% and 7.7%, respectively, describing a continuously increasing trend. In 2018, the NHIFA spent 42.31 million EUR on the treatment of hip osteoarthritis. Hip osteoarthritis accounts for 1% of total nationwide health insurance expenditures. 36.8% of costs were attributed to the treatment of male patients, and 63.2% to female patients. Acute inpatient care, outpatient care and chronic and rehabilitation inpatient care were the main cost drivers, accounting for 62.7%, 14.6% and 8.2% of the total health care expenditure for men, and 51.0%, 20.0% and 11.2% for women, respectively. The average annual treatment cost per patient was 3,627 EUR for men and 4,194 EUR for women.
Conclusions: The prevalence of hip osteoarthritis was 1.96 times higher (the age-standardised prevalence was 1.5 times higher) in women compared to men. Acute inpatient care was the major cost driver in the treatment of hip osteoarthritis. The average annual treatment cost per patient was 15.6% higher for women compared to men.
Keywords: Acute inpatient care; Disease burden; Financing; Health insurance; Hip osteoarthritis; Outpatient care.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
[Annual epidemiological and health insurance disease burden of pertrochanteric fractures in Hungary].Orv Hetil. 2021 Mar 28;162(162 Suppl 1):46-53. doi: 10.1556/650.2021.32162. Orv Hetil. 2021. PMID: 33774608 Hungarian.
-
[The nationwide epidemiological and health insurance disease burden of knee and lower leg injuries in Hungary].Orv Hetil. 2021 Mar 28;162(162 Suppl 1):54-60. doi: 10.1556/650.2021.32160. Orv Hetil. 2021. PMID: 33774609 Hungarian.
-
[Nationwide epidemiological and health insurance disease burden of rheumatoid arthritis in Hungary].Orv Hetil. 2021 Mar 28;162(162 Suppl 1):30-37. doi: 10.1556/650.2021.32157. Orv Hetil. 2021. PMID: 33774606 Hungarian.
-
[Epidemiological disease burden and annual health insurance treatment cost of colorectal cancer in Hungary].Orv Hetil. 2021 Mar 28;162(162 Suppl 1):14-21. doi: 10.1556/650.2021.32152. Orv Hetil. 2021. PMID: 33774604 Hungarian.
-
Economic costs of diabetes in the U.S. In 2007.Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Diabetes Care. 2008. PMID: 18308683 Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources